title: Species-specific effects on hemolymph glucose control by serotonin, dopamine, and L-enkephalin and their inhibitors in Squilla mantis and Astacus leptodactylus (crustacea).
abstract: Hemolymph glucose level is controlled by crustacean Hyperglycemic Hormone (cHH) released from the eyestalk neuroendocrine centers under conditions of both physiological and environmental stress. Biogenic amines and enkephalin have been found to mediate the release of several neurohormones from crustacean neuroendocrine tissue. We investigated the effect of serotonin, dopamine, and Leucine-enkephalin in vivo--injected into the stomatopod Squilla mantis and the decapod Astacus leptodactylus--whether increasing or depressing glycemia. Serotonin had a marked effect in elevating glucose level compared with initial values in both species. 5-HT1-like receptors are more involved in mediating serotonin action as co-injected cyproheptadine was a more effective antagonist than ketanserin (5-HT2-like receptor inhibitor). Dopamine injection in intact animals produced a decrease below initial levels of hemolymph glucose. This effect was significantly antagonized by domperidone. No significant effect of both amines occurred in eyestalkless animals. L-enkephalin shows a differential effect: in S. mantis it induced hypoglycemia while in A. leptodactylus it caused an increase of glucose level. Co-injected antagonist naloxone affected the direction of the response. Serotonin appears to provide a major control on glucose mobilization, whereas dopamine and L-enkephalin act as modulators whose plasticity in use or action varies among species.
authors.affiliation: BRAIN Center for Neuroscience, Department of Biology, Via Giorgieri 7, University of Trieste I-34127 Trieste, Italy.
authors.forename: Simonetta
authors.initials: S
authors.lastname: Lorenzon
authors.forename: Sara
authors.initials: S
authors.lastname: Brezovec
authors.forename: Enrico A
authors.initials: EA
authors.lastname: Ferrero
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D033364:Decapoda / Q000378:metabolism*; D004294:Domperidone; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004745:Enkephalins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006458:Hemolymph / Q000378:metabolism*; D009270:Naloxone; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013045:Species Specificity
chemical_list: D001786:Blood Glucose; D018492:Dopamine Antagonists; D004745:Enkephalins; D012702:Serotonin Antagonists; D012701:Serotonin; D009270:Naloxone; D004294:Domperidone; D004298:Dopamine